15th Annual Conference of the Metabolomics Society (Metabolomics) Jun 23, 2019 20190623 Jun 27, 2019 The Hague, Netherlands The Metabolomics Society is an independent, non-profit organization, governed by a Board of Directors composed of dedicated members of the metabolomics community but ultimately responsive to its members. The Metabolomics Society's vision is to become the premier organization devoted to the development of metabolism-based research. Constituted in 2004, the Metabolomics Society now has more than a 1,000 members in more than 40 countries. Metabolomics is a newly emerging field of "omics" research concerned with the comprehensive characterization of the small molecule metabolites in biological systems. It can provide an overview of the metabolic status and global biochemical events associated with a cellular or biological system. An increasing focus in metabolomics research is now evident in academia, industry and government, with more than 500 papers a year being published on this subject. The concept of Systems Biology and the prospect of integrating transcriptomics, proteomics, and metabolomics data is exciting and the integration of these fields continues to evolve at a rapid pace. /content/dam/pmiscience/default-fallback-thumbnails/conference/phillip-morris-science-detail-background.png

      15th Annual Conference of the Metabolomics Society (Metabolomics)

      Date
      Jun 23, 2019 - Jun 27, 2019
      Location
      The Hague, Netherlands
      The Metabolomics Society is an independent, non-profit organization, governed by a Board of Directors composed of dedicated members of the metabolomics community but ultimately responsive to its members. The Metabolomics Society's vision is to become the premier organization devoted to the development of metabolism-based research. Constituted in 2004, the Metabolomics Society now has more than a 1,000 members in more than 40 countries. Metabolomics is a newly emerging field of "omics" research concerned with the comprehensive characterization of the small molecule metabolites in biological systems. It can provide an overview of the metabolic status and global biochemical events associated with a cellular or biological system. An increasing focus in metabolomics research is now evident in academia, industry and government, with more than 500 papers a year being published on this subject. The concept of Systems Biology and the prospect of integrating transcriptomics, proteomics, and metabolomics data is exciting and the integration of these fields continues to evolve at a rapid pace.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.